Christopher Richard Anzalone - Net Worth and Insider Trading

Christopher Richard Anzalone Net Worth

The estimated net worth of Christopher Richard Anzalone is at least $89 Million dollars as of 2024-04-23. Christopher Richard Anzalone is the CEO of Arrowhead Pharmaceuticals Inc and owns about 3,715,048 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $89 Million. Details can be seen in Christopher Richard Anzalone's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Richard Anzalone has not made any transactions after 2024-01-31 and currently still holds the listed stock(s).

Transaction Summary of Christopher Richard Anzalone

To

Christopher Richard Anzalone Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Richard Anzalone owns 1 companies in total, including Arrowhead Pharmaceuticals Inc () .

Click here to see the complete history of Christopher Richard Anzalone’s form 4 insider trades.

Insider Ownership Summary of Christopher Richard Anzalone

Ticker Comapny Transaction Date Type of Owner
Arrowhead Pharmaceuticals Inc 2024-01-31 director & President and CEO

Christopher Richard Anzalone Latest Holdings Summary

Christopher Richard Anzalone currently owns a total of 1 stock. Christopher Richard Anzalone owns 3,715,048 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 31, 2024, with a value of $89 Million.

Latest Holdings of Christopher Richard Anzalone

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARWR Arrowhead Pharmaceuticals Inc 2024-01-31 3,715,048 23.92 88,863,948

Holding Weightings of Christopher Richard Anzalone


Christopher Richard Anzalone Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Richard Anzalone has made a total of 19 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 57,499 shares on January 31, 2024, which brought Christopher Richard Anzalone around $2 Million.

Insider Trading History of Christopher Richard Anzalone

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Richard Anzalone Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Richard Anzalone Ownership Network

Ownership Network List of Christopher Richard Anzalone

No Data

Ownership Network Relation of Christopher Richard Anzalone


Christopher Richard Anzalone Owned Company Details

What does Arrowhead Pharmaceuticals Inc do?

Who are the key executives at Arrowhead Pharmaceuticals Inc?

Christopher Richard Anzalone is the director & President and CEO of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include other: Senior Vice President James C Hamilton , CFO Kenneth Allen Myszkowski , and Chief Medical Officer Martin Javier San .

Arrowhead Pharmaceuticals Inc () Insider Trades Summary

Over the past 18 months, Christopher Richard Anzalone made 6 insider transaction in Arrowhead Pharmaceuticals Inc () with a net sale of 266,472. Other recent insider transactions involving Arrowhead Pharmaceuticals Inc () include a net sale of 79,524 shares made by James C Hamilton , a net sale of 101,729 shares made by Kenneth Allen Myszkowski , and a net sale of 65,690 shares made by Patrick O'brien .

In summary, during the past 3 months, insiders sold 103,499 shares of Arrowhead Pharmaceuticals Inc () in total and bought 3,000 shares, with a net sale of 100,499 shares. During the past 18 months, 608,104 shares of Arrowhead Pharmaceuticals Inc () were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 605,104 shares.

Arrowhead Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arrowhead Pharmaceuticals Inc Insider Transactions

No Available Data

Christopher Richard Anzalone Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Richard Anzalone. You might contact Christopher Richard Anzalone via mailing address: Arrowhead Research Corporation, 201 South Lake Avenue, Suite 703, Pasadena Ca 91101.

Discussions on Christopher Richard Anzalone

No discussions yet.